Plasma interleukin-6 levels of both CRC groups was significantly higher, compared to those in the control group (CgA−: p = 0.0037, CgA+: p = 0.0090), but did not differ between the tumor cohorts (p = 0.9483; Figure 1C). This evidence concerns the gene CGA and colorectal carcinoma.